Fortis Healthcare Limited (BOM:532843)
India
· Delayed Price · Currency is INR 664.80
+2.45 (0.37%)
At close: May 9, 2025
Fortis Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2015 - 2019 |
| Revenue | 68,929 | 62,976 | 57,176 | 40,301 | 46,323 | Upgrade
|
| Revenue Growth (YoY) | 9.45% | 10.14% | 41.87% | -13.00% | 3.65% | Upgrade
|
| Cost of Revenue | 43,834 | 39,894 | 24,923 | 19,582 | 20,175 | Upgrade
|
| Gross Profit | 25,095 | 23,082 | 32,253 | 20,719 | 26,148 | Upgrade
|
| Selling, General & Admin | 3,417 | 3,084 | 2,265 | 1,321 | 2,447 | Upgrade
|
| Other Operating Expenses | 9,100 | 8,997 | 19,340 | 15,308 | 17,674 | Upgrade
|
| Operating Expenses | 15,942 | 15,239 | 24,650 | 19,536 | 23,039 | Upgrade
|
| Operating Income | 9,153 | 7,844 | 7,603 | 1,183 | 3,110 | Upgrade
|
| Interest Expense | -936.01 | -985.87 | -1,194 | -1,408 | -1,720 | Upgrade
|
| Interest & Investment Income | 298.94 | 238.29 | 215.48 | 420.13 | 303.05 | Upgrade
|
| Earnings From Equity Investments | 95.1 | 218.4 | 241.47 | 475.59 | 121.66 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 154.6 | 15.9 | -121 | 188.5 | Upgrade
|
| Other Non Operating Income (Expenses) | -228.3 | -178.43 | -188.94 | -146.17 | -221.84 | Upgrade
|
| EBT Excluding Unusual Items | 8,383 | 7,291 | 6,693 | 403.72 | 1,781 | Upgrade
|
| Impairment of Goodwill | - | - | -123.11 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.81 | 7.4 | - | - | 4.12 | Upgrade
|
| Gain (Loss) on Sale of Assets | 35.02 | 169.08 | 35.22 | 17.69 | -8.72 | Upgrade
|
| Legal Settlements | -1.9 | -4.35 | -0.53 | -0.57 | -1.04 | Upgrade
|
| Other Unusual Items | 160.2 | 736.1 | 3,273 | 12.12 | 618.29 | Upgrade
|
| Pretax Income | 8,580 | 8,199 | 9,878 | 432.95 | 2,394 | Upgrade
|
| Income Tax Expense | 2,128 | 1,869 | 1,978 | 994.64 | 1,479 | Upgrade
|
| Earnings From Continuing Operations | 6,452 | 6,330 | 7,899 | -561.69 | 914.88 | Upgrade
|
| Net Income to Company | 6,452 | 6,330 | 7,899 | -561.69 | 914.88 | Upgrade
|
| Minority Interest in Earnings | -463.4 | -442.5 | -2,348 | -535.93 | -335.53 | Upgrade
|
| Net Income | 5,989 | 5,887 | 5,551 | -1,098 | 579.36 | Upgrade
|
| Net Income to Common | 5,989 | 5,887 | 5,551 | -1,098 | 579.36 | Upgrade
|
| Net Income Growth | 1.72% | 6.05% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 755 | 755 | 755 | 755 | 755 | Upgrade
|
| Shares Outstanding (Diluted) | 755 | 755 | 755 | 755 | 755 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 24.03% | Upgrade
|
| EPS (Basic) | 7.93 | 7.80 | 7.35 | -1.45 | 0.77 | Upgrade
|
| EPS (Diluted) | 7.93 | 7.80 | 7.35 | -1.45 | 0.77 | Upgrade
|
| EPS Growth | 1.69% | 6.10% | - | - | - | Upgrade
|
| Free Cash Flow | 1,576 | 3,750 | 6,499 | 2,670 | 156.58 | Upgrade
|
| Free Cash Flow Per Share | 2.09 | 4.97 | 8.61 | 3.54 | 0.21 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | - | - | - | Upgrade
|
| Gross Margin | 36.41% | 36.65% | 56.41% | 51.41% | 56.45% | Upgrade
|
| Operating Margin | 13.28% | 12.46% | 13.30% | 2.94% | 6.71% | Upgrade
|
| Profit Margin | 8.69% | 9.35% | 9.71% | -2.72% | 1.25% | Upgrade
|
| Free Cash Flow Margin | 2.29% | 5.96% | 11.37% | 6.63% | 0.34% | Upgrade
|
| EBITDA | 11,829 | 10,369 | 9,956 | 3,470 | 5,325 | Upgrade
|
| EBITDA Margin | 17.16% | 16.46% | 17.41% | 8.61% | 11.50% | Upgrade
|
| D&A For EBITDA | 2,676 | 2,525 | 2,353 | 2,288 | 2,216 | Upgrade
|
| EBIT | 9,153 | 7,844 | 7,603 | 1,183 | 3,110 | Upgrade
|
| EBIT Margin | 13.28% | 12.46% | 13.30% | 2.94% | 6.71% | Upgrade
|
| Effective Tax Rate | 24.80% | 22.80% | 20.03% | 229.73% | 61.78% | Upgrade
|
| Revenue as Reported | 69,312 | 63,594 | 57,449 | 40,767 | 46,850 | Upgrade
|
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.